Literature DB >> 27997410

Influence of nutrition therapy on the intestinal microbiome.

Monika A Krezalek1, Andrew Yeh, John C Alverdy, Michael Morowitz.   

Abstract

PURPOSE OF REVIEW: This review describes the relationship between nutritional therapies and the intestinal microbiome of critically ill patients. RECENT
FINDINGS: The intestinal microbiome of the critically ill displays a near complete loss of health-promoting microbiota with overgrowth of virulent healthcare-associated pathogens. Early enteral nutrition within 24 h of admission to the ICU has been advocated in medical and surgical patients to avoid derangements of the intestinal epithelium and the microbiome associated with starvation. Contrary to previous dogma, permissive enteral underfeeding has recently been shown to have similar outcomes to full feeding in the critically ill, whereas overfeeding has been shown to be deleterious in those patients who are not malnourished at baseline. Randomized clinical trials suggest that peripheral nutrition can be used safely either as the sole or supplemental source of nutrition even during the early phases of critical care. The use of probiotics has been associated with a significant reduction in infectious complications in the critically ill without a notable mortality benefit.
SUMMARY: Focus of research is shifting toward strategies that augment the intestinal environment to facilitate growth of beneficial microorganisms, strengthen colonization resistance, and maintain immune homeostasis.

Entities:  

Mesh:

Year:  2017        PMID: 27997410     DOI: 10.1097/MCO.0000000000000348

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  15 in total

Review 1.  The microbiome and nutrition in critical illness.

Authors:  Takehiko Oami; Deena B Chihade; Craig M Coopersmith
Journal:  Curr Opin Crit Care       Date:  2019-04       Impact factor: 3.687

2.  Rationale for and Design of the Study of Early Enteral Dextrose in Sepsis: A Pilot Placebo-Controlled Randomized Clinical Trial.

Authors:  Faraaz Ali Shah; Georgios D Kitsios; Yingze Zhang; Alison Morris; Sachin Yende; David T Huang; Christopher P O'Donnell; Bryan J McVerry
Journal:  JPEN J Parenter Enteral Nutr       Date:  2019-05-30       Impact factor: 4.016

3.  Enteral Nutrition Can Be Given to Patients on Vasopressors.

Authors:  Paul E Wischmeyer
Journal:  Crit Care Med       Date:  2020-01       Impact factor: 7.598

Review 4.  The gut microbiome in anorexia nervosa: relevance for nutritional rehabilitation.

Authors:  Anu Ruusunen; Tetyana Rocks; Felice Jacka; Amy Loughman
Journal:  Psychopharmacology (Berl)       Date:  2019-01-05       Impact factor: 4.530

Review 5.  Re-examining chemically defined liquid diets through the lens of the microbiome.

Authors:  Tiffany Toni; John Alverdy; Victoria Gershuni
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-09-30       Impact factor: 46.802

Review 6.  Gut integrity in critical illness.

Authors:  Shunsuke Otani; Craig M Coopersmith
Journal:  J Intensive Care       Date:  2019-03-20

Review 7.  The role of nutritional support in the physical and functional recovery of critically ill patients: a narrative review.

Authors:  Danielle E Bear; Liesl Wandrag; Judith L Merriweather; Bronwen Connolly; Nicholas Hart; Michael P W Grocott
Journal:  Crit Care       Date:  2017-08-26       Impact factor: 9.097

Review 8.  Insights into the role of intestinal microbiota in hematopoietic stem-cell transplantation.

Authors:  Daniele Zama; Gianluca Bossù; Davide Leardini; Edoardo Muratore; Elena Biagi; Arcangelo Prete; Andrea Pession; Riccardo Masetti
Journal:  Ther Adv Hematol       Date:  2020-01-20

Review 9.  Dietary Protein and Muscle in Aging People: The Potential Role of the Gut Microbiome.

Authors:  Mary Ni Lochlainn; Ruth C E Bowyer; Claire J Steves
Journal:  Nutrients       Date:  2018-07-20       Impact factor: 5.717

Review 10.  Reconsidering ventilator-associated pneumonia from a new dimension of the lung microbiome.

Authors:  Laia Fernández-Barat; Ruben López-Aladid; Antoni Torres
Journal:  EBioMedicine       Date:  2020-09-16       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.